Trial Profile
A Phase II Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2011
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 06 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Jun 2011 Status changed from active, no longer recruiting to recruiting as reported by ClincalTrials.gov.
- 08 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClincalTrials.gov.